Cedars-Sinai Pharmacists Attending Midyear Clinical Meeting 2024

Cedars-Sinai experts in pharmacy services attending the Dec. 8-12 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting 2024 in New Orleans are available for interviews about the latest developments in patient safety and pharmacy practice.

Cedars-Sinai Experts Available to Discuss Healthy Aging During GSA 2024

Experts on healthy aging from Cedars-Sinai’s growing Center for Translational Geroscience and Geriatrics Program will present their latest research and clinical advances at The Gerontological Society of America’s (GSA) 2024 Annual Scientific Meeting in Seattle, Nov. 13-16.

5 Keys to Effective Medication Safety at Home

Children’s Hospital Los Angeles has long been a forceful leader on the issue of medication safety, advising parents on what they can do at home to prevent their kids from ingesting prescription drugs that can do them great harm.Effective medication safety requires adhering to a few simple rules. We break those down here with the guidance of Helen Arbogast, DrPH, MPH, Manager of CHLA’s Injury Prevention Program, and CHLA pediatric surgeon Lorraine Kelley-Quon, MD, MSHS, FACS, FAAP, who oversees the Health Outcomes and Policy Effects (HOPE) Laboratory, which devotes a good portion of its research to studying the risks associated with opioid use for infants, children and adolescents.

Study finds oral testosterone therapy undecanoate is effective, with no liver toxicity

An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with low testosterone levels, with no evidence of liver toxicity. The findings are being presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.